November 2, 2022 Comments Off on New patent expiration for Duchesnay drug OSPHENA Posted in: Uncategorized
Annual Drug Patent Expirations for OSPHENA Osphena is a drug marketed by Duchesnay and is included in one NDA. It is available from one supplier. There are eight patents protecting…
The post New patent expiration for Duchesnay drug OSPHENA appeared fir…
October 29, 2022 Comments Off on New patent expiration for Novartis drug RYDAPT Posted in: Uncategorized
Annual Drug Patent Expirations for RYDAPT Rydapt is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Novartis drug RYDAPT appeared first on…